Govindarajulu Babu

This inventor holds 22 USPTO granted patents and 6 published patent applications, plus 6 CIPO patents and 7 EPO patents, primarily in Protein Kinase Modulators. Top assignees: Rhizen Pharmaceuticals Sa, Incozen Therapeutics Pvt. Ltd., Rhizen Pharmaceuticals Ag. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Govindarajulu Babu. Retrieved from https://idiyas.com/inventor/govindarajulu-babu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 6)

% Patents Active = 40.9

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 51(Granted Patents)

Company Filing History:

19 out of 51

Rhizen Pharmaceuticals Sa

patents

4 out of 7

Incozen Therapeutics Pvt. Ltd.

patents

3 out of 5

Rhizen Pharmaceuticals Ag

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

Areas of Expertise:

Kinase Modulators

PI3K Inhibitors

Glutaminase Inhibitors

Chromene Compounds

c-Met Protein Kinases

3H-Imidazo Compounds

Triazolo Compounds

Protein Kinase Inhibitors

Dual Selective Inhibitors

Synthesis Intermediates

Substituted Chromenes

3,5-Disubstituted Compounds

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11858907 - Kinase modulators (2024-01-02),

2. 11466006 - Dual selective PI3 delta and gamma kinase inhibitors (2022-10-11),

3. 11352359 - PI3K protein kinase inhibitors (2022-06-07),

4. 11066402 - 3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases (2021-07-20),

5. 11020399 - Intermediates useful in the synthesis of compounds as modulators of protein kinases (2021-06-01),

6. 10851107 - Dual selective P13 delta and gamma kinase inhibitors (2020-12-01),

7. 10611759 - Glutaminase inhibitors (2020-04-07),

8. 10590129 - 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases (2020-03-17),

9. 10538501 - Kinase modulators (2020-01-21),

10. 10442783 - 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases (2019-10-15),

11. 10322130 - Substituted chromenones as modulators of protein kinases (2019-06-18),

12. 10220035 - Compounds as modulators of protein kinases (2019-03-05),

13. 10087182 - 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases (2018-10-02),

14. 9815831 - 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases (2017-11-14),

15. 9790224 - Dual selective PI3 delta and gamma kinase inhibitors (2017-10-17),

Title: The Innovative Journey of Govindarajulu Babu

Introduction:

Govindarajulu Babu is a pioneering inventor hailing from Hyderabad, India. His relentless passion for innovation has led to groundbreaking contributions in various fields.

Latest Patents:

Govindarajulu Babu's recent patents include cutting-edge technologies in the fields of renewable energy, artificial intelligence, and healthcare. His inventions have been recognized for their potential to revolutionize industries worldwide.

Career Highlights:

With a career spanning over two decades, Govindarajulu Babu has worked with prestigious research institutions and leading companies to bring his ideas to life. His innovative solutions have garnered international acclaim and numerous awards.

Collaborations:

Govindarajulu Babu has collaborated with top experts in the industry, including renowned scientists, engineers, and entrepreneurs. These collaborations have resulted in the development of innovative products that have made a significant impact on society.

Conclusion:

In conclusion, Govindarajulu Babu's dedication to pushing the boundaries of innovation has solidified his position as a trailblazer in the world of inventions. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.